Literature DB >> 15836980

Essential role of the synaptic vesicle protein synapsin II in formalin-induced hyperalgesia and glutamate release in the spinal cord.

Achim Schmidtko1, Domenico Del Turco, Ovidiu Coste, Corina Ehnert, Ellen Niederberger, Peter Ruth, Thomas Deller, Gerd Geisslinger, Irmgard Tegeder.   

Abstract

The synaptic vesicle protein synapsin II plays an important role in the regulation of neurotransmitter release and synaptic plasticity. Here, we investigated its involvement in the synaptic transmission of nociceptive signals in the spinal cord and the development of pain hypersensitivity. We show that synapsin II is predominantly expressed in terminals and neuronal fibers in superficial laminae of the dorsal horn (laminae I-II). Formalin injection into a mouse hindpaw normally causes an immediate and strong release of glutamate in the dorsal horn. In synapsin II deficient mice this glutamate release is almost completely missing. This is associated with reduced nociceptive behavior in the formalin test and in the zymosan-induced paw inflammation model. In addition, the formalin evoked increase in the number of c-Fos IR neurons is significantly reduced in synapsin II knockout mice. Touch perception and motor coordination, however, are normal indicating that synapsin II deficiency does not generally disrupt sensory and/or motor functions. Antisense-mediated transient knockdown of synapsin II in the spinal cord of adult animals also reduced the nociceptive behavior. As the antisense effect is independent of a potential role of synapsin II during development we suggest that the hypoalgesia in synapsin II deficient mice does involve a direct 'pain-facilitating' effect of synapsin II and is not essentially dependent on potentially occurring developmental alterations. The distinctive role of synapsin II for pain signaling probably results from its specific localization and possibly from a specific control of glutamate release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15836980     DOI: 10.1016/j.pain.2005.02.027

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  8 in total

Review 1.  [Pharmacological aspects of pain research in Germany].

Authors:  E Niederberger; R Kuner; G Geißlinger
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

2.  Colitis induces calcitonin gene-related peptide expression and Akt activation in rat primary afferent pathways.

Authors:  Li-Ya Qiao; John R Grider
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

Review 3.  The Role of Synapsins in Neurological Disorders.

Authors:  Fatima Javed Mirza; Saadia Zahid
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

4.  Peripheral calcium-permeable AMPA receptors regulate chronic inflammatory pain in mice.

Authors:  Vijayan Gangadharan; Rui Wang; Bettina Ulzhöfer; Ceng Luo; Rita Bardoni; Kiran Kumar Bali; Nitin Agarwal; Irmgard Tegeder; Ullrich Hildebrandt; Gergely G Nagy; Andrew J Todd; Alessia Ghirri; Annette Häussler; Rolf Sprengel; Peter H Seeburg; Amy B MacDermott; Gary R Lewin; Rohini Kuner
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

5.  Slack Potassium Channels Modulate TRPA1-Mediated Nociception in Sensory Neurons.

Authors:  Fangyuan Zhou; Katharina Metzner; Patrick Engel; Annika Balzulat; Marco Sisignano; Peter Ruth; Robert Lukowski; Achim Schmidtko; Ruirui Lu
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

6.  R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids.

Authors:  Philipp Bishay; Helmut Schmidt; Claudiu Marian; Annett Häussler; Nina Wijnvoord; Simone Ziebell; Julia Metzner; Marco Koch; Thekla Myrczek; Ingo Bechmann; Rohini Kuner; Michael Costigan; Faramarz Dehghani; Gerd Geisslinger; Irmgard Tegeder
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

7.  cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I.

Authors:  Achim Schmidtko; Wei Gao; Peter König; Sandra Heine; Roberto Motterlini; Peter Ruth; Jens Schlossmann; Doris Koesling; Ellen Niederberger; Irmgard Tegeder; Andreas Friebe; Gerd Geisslinger
Journal:  J Neurosci       Date:  2008-08-20       Impact factor: 6.167

8.  Antioxidant activity of sestrin 2 controls neuropathic pain after peripheral nerve injury.

Authors:  Wiebke Kallenborn-Gerhardt; Ruirui Lu; Katharina M J Syhr; Juliana Heidler; Harald von Melchner; Gerd Geisslinger; Thorsten Bangsow; Achim Schmidtko
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.